People: Stryker Corp (SYK)

SYK on New York Consolidated

68.90USD
17 May 2013
Price Change (% chg)

$-0.16 (-0.23%)
Prev Close
$69.06
Open
$68.61
Day's High
$68.97
Day's Low
$68.28
Volume
3,312,031
Avg. Vol
1,605,413
52-wk High
$69.81
52-wk Low
$49.43

Search Stocks

Summary

Name Age Since Current Position

William Parfet

 66 2012 Non-Executive Independent Chairman of the Board

Kevin Lobo

 47 2012 President, Chief Executive Officer, Director

William Jellison

 55 2013 Chief Financial Officer, Vice President

Lonny Carpenter

 51 2009 Group President - Global Quality and Operations

David Floyd

 52 2012 Group President - Orthopaedics

Timothy Scannell

 48 2009 Group President - MedSurg and Spine

Ramesh Subrahmanian

 51 2011 Group President - International

Tony McKinney

 43 2008 Vice President, Chief Accounting Officer

Curtis Hall

 56 2011 Vice President, General Counsel

Steven Benscoter

 45 2012 Vice President - Human Resources

Katherine Owen

 42 2007 Vice President - Strategy and Investor Relations

Dean Bergy

 53 2013 Vice President, Corporate Secretary

Howard Cox

 69 1974 Independent Director

Srikant Datar

 60 2009 Independent Director

Roch Doliveux

 56 2010 Independent Director

Louise Francesconi

 60 2006 Independent Director

Allan Golston

 46 2011 Independent Director

Howard Lance

 57 2009 Independent Director

Ronda Stryker

 58 1984 Independent Director
» Insider Trading

Biographies

Name Description

William Parfet

 Mr. William U. Parfet is Non-Executive Independent Chairman of the Board of Stryker Corp., since February 8, 2012. He has served as Chairman and Chief Executive Officer of MPI Research, Inc., a drug safety and pharmaceutical development company, since 1999. He is also a director of Monsanto Company, a provider of agricultural products that improve farm productivity, and Taubman Centers, Inc., a real estate development company.

Kevin Lobo

 Mr. Kevin A. Lobo has been appointed as President, Chief Executive Officer, Director of Stryker Corp., effective October 1, 2012. He has had a 25-year business career that includes executive positions in general management and finance. He joined Stryker in April 2011 as Group President of the Neurotechnology and Spine Group and in June 2011 was appointed Group President, Orthopaedics. Before joining Stryker, Mr. Lobo had held a number of senior-level leadership roles at Johnson & Johnson and, since 2006, had been President of Johnson & Johnson's Ethicon Endo-Surgery subsidiary. Prior to joining Johnson & Johnson, Mr. Lobo held finance positions at KPMG, Unilever Canada and Kraft Canada and subsequently held executive positions at Rhone-Poulenc.

William Jellison

 Mr. William R. Jellison has been appointed as Chief Financial Officer, Vice President of Stryker Corporation effective April 22, 2013. He has been employed by Dentsply International Inc., a manufacturer of dental and other consumable medical device products, for the past 15 years, most recently as Senior Vice President and Chief Financial Officer since January 2005, a position he also held from April 1998 until November 2002. From November 2002 until January 2005, Mr. Jellison served as a Senior Vice President of Dentsply, with domestic and international operating responsibilities. Prior to April 1998, Mr. Jellison held various financial management positions, including Vice President of Finance, Treasurer and Corporate Controller, for Donnelly Corporation, an international automotive parts supplier, since 1980. Mr. Jellison graduated from Hope College with a bachelor's degree in business administration, became a Certified Management Accountant and is a member of both the IMA and FEI.

Lonny Carpenter

 Mr. Lonny J. Carpenter is Group President - Global Quality and Operations of Stryker Corp., since September 1, 2009. He was the Group President, Instruments and Medical since November 2008. He had previously been President, Stryker Medical since May 2008 and Vice President and General Manager, Stryker Medical since 2006. After joining the Company in 1989, Mr. Carpenter held various roles of increasing responsibility at Stryker Instruments before being promoted to Vice President, Global Operations, Stryker Instruments in 2004.

David Floyd

 Mr. David K. Floyd has been appointed as Group President, Orthopaedics of Stryker Corp., effective November 15, 2012. Mr. Floyd joins Stryker after 25 years in the medical technology and orthopaedics industry where he held a number of senior level leadership roles at DePuy, a division of Johnson and Johnson, Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics and most recently as Chief Executive Officer for OrthoWorx.

Timothy Scannell

 Mr. Timothy J. Scannell is Group President - MedSurg and Spine of Stryker Corp., since September 1, 2009. He was Group President, Spine and Endoscopy since November 2008. He had previously been President, Stryker Spine since 2005 and Vice President and General Manager, Stryker Spine since 2003. After joining the Company in 1990, Mr. Scannell is leadership roles at Stryker Endoscopy before being promoted to Vice President and General Manager, Stryker Biotech in 2001.

Ramesh Subrahmanian

 Mr. Ramesh Subrahmanian is Group President - International of Stryker Corp since September 1, 2011. He joins Stryker after twenty-three years in the pharmaceutical industry where he held a number of senior level leadership roles at Merck, Sanofi-Aventis and Hoechst Marion Roussel Ltd., most recently as Senior Vice President & President, Asia Pacific for Merck & Co. Inc. In his new role, he will have responsibilities for the Company's international business units and will be based in Singapore.

Tony McKinney

 Mr. Tony M. McKinney is Chief Accounting Officer, Vice President of Stryker Corp., since November 2008. He had previously been the Vice President, Finance, International Group since 2006 and Group Controller, International Group since 2004. After joining the Company in 1995, Mr. McKinney held roles of increasing responsibility in the Corporate Accounting department before becoming the Director, Finance for the Japan Division in 2002. Prior to joining the Company in 1995, Mr. McKinney was an Audit Senior Accountant with Ernst & Young LLP.

Curtis Hall

 Mr. Curtis E. Hall, Esq., is Vice President, General Counsel of Stryker Corp., since June 2004. He was appointed Vice President and General Counsel of the Company in June 2004, and was also appointed Secretary of the Company in June, 2010. He had previously been General Counsel for the Company since 1994. Prior to joining the Company, he was a partner in the Michigan law firm of Miller, Canfield, Paddock and Stone, an Assistant United States Attorney in Washington, D.C. and an Assistant District Attorney in New York City.

Steven Benscoter

 Mr. Steven P. Benscoter has been appointed as Vice President, Human Resources of Stryker Corp., effective 2012.

Katherine Owen

 Ms. Katherine Ann Owen is Vice President - Strategy and Investor Relations of Stryker Corp., since February 15, 2007. Prior to joining the Company, she served as a medical technology analyst at Merrill Lynch. Prior to that she held a similar position at Cowen & Co./SG Cowen and had been a corporate lending analyst at State Street Bank.

Dean Bergy

 Mr. Dean H. Bergy is Vice President, Corporate Secretary of Stryker Corporation. He is no longer Interim Chief Financial Officer of the company effective April 22, 2013. He had previously been Vice President, Chief Financial Officer from January 2003 to March 2009, has been appointed Interim Chief Financial Officer effective October 1, 2012. Following his resignation as Vice President, Chief Financial Officer, Mr. Bergy continued to be employed by the Company as an Advisor to the CFO and was elected Secretary of the Company in September 2011 and Vice President, Corporate Secretary in September 2012.

Howard Cox

 Mr. Howard E. Cox, Jr., is Independent Director of Stryker Corp., since 1974. He is Partner of Greylock and its affiliated venture capital partnerships since 1971. He is also a member of the Harvard Medical School Board of Fellows and of the Investment Committees of the Dana Farber Cancer Institute, Partners Healthcare System, Inc. and the Boston Museum of Fine Arts.

Srikant Datar

 Dr. Srikant M. Datar, Ph.D., is Independent Director of Stryker Corp., since July 29, 2009. He serves at Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University since 1996 and Senior Associate Dean from 2001 to 2010. Prior to 1996, he was Professor, Accounting and Management, since 1989 at Stanford University. He is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc. a management, technology and policy consulting firm and KPIT Cummins Infosystems Ltd. (India), a global IT consulting and product engineering partner company.

Roch Doliveux

 Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He served as CEO and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, since 2005. He was also CEO of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation.

Louise Francesconi

 Ms. Louise L. Francesconi is Independent Director of Stryker Corp., since July 26, 2006. Former Vice President of Raytheon Company and former President of Raytheon Missile Systems, which she led from 1996 to July 2008. She is also Chairman of the Tucson Medical Center Healthcare Board of Trustees and a director of Unisource Energy Corporation, a utility that delivers natural gas and electric service, and Global Solar Energy, Inc., a producer of solar cells.

Allan Golston

 Mr. Allan C. Golston is Independent Director of Stryker Corp., since January 1, 2011. He served as President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Malt-O-Meal, a privately held breakfast cereal corporation, where he is the Chair of the Audit Committee. Mr. Golston has experience in auditing, finance and the health care industry. He is a Certified Public Accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital.

Howard Lance

 Mr. Howard L. Lance is Independent Director of Stryker Corp., since April 29, 2009. He is Executive Advisor to The Blackstone Group L.P., a private equity firm, since August 2012. Former Chairman, President and Chief Executive Officer of Harris Corporation, an international communications and information technology company, from January 2003 to December 2011. He is also a director of Eastman Chemical Company, a worldwide manufacturer of chemicals, fibers and plastics, Emdeon Inc., a healthcare information technology company, Summit Materials, a privately-held provider of aggregates, ready-mix concrete, cement and asphalt to the construction industry, and was a director at Harris Stratex Networks Inc., a provider of wireless transmission systems and network management software from 2007 to 2009.

Ronda Stryker

 Ms. Ronda E. Stryker is Independent Director of Stryker Corp., since 1984. She is also Vice Chair and a director of Greenleaf Trust, a bank, a trustee of Spelman College and of Kalamazoo College and Vice Chairperson of the Kalamazoo Community Foundation.

Insider Trading

Name Shares Traded Price

STRYKER RONDA E

 7,000 $68.95

STRYKER RONDA E

 7,000 $68.61

STRYKER RONDA E

 7,000 $67.47

STRYKER RONDA E

 7,000 $66.61

COX HOWARD ELLIS JR

 20,000 $66.12

STRYKER RONDA E

 7,000 $66.19

STRYKER RONDA E

 7,000 $66.23

STRYKER RONDA E

 7,000 $66.40

STRYKER RONDA E

 7,000 $66.35

STRYKER RONDA E

 7,000 $66.27

CARPENTER LONNY J

 6,000 $65.53

STRYKER RONDA E

 7,000 $65.67

STRYKER RONDA E

 7,000 $65.18

STRYKER RONDA E

 7,000 $65.53

STRYKER RONDA E

 7,000 $64.90

STRYKER RONDA E

 7,000 $65.59

STRYKER RONDA E

 7,000 $65.09

STRYKER RONDA E

 7,000 $64.86

STRYKER RONDA E

 7,000 $63.96

STRYKER RONDA E

 7,000 $63.97

STRYKER RONDA E

 7,000 $63.58

STRYKER RONDA E

 7,000 $64.42

STRYKER RONDA E

 7,000 $64.86

STRYKER RONDA E

 7,000 $65.82

STRYKER RONDA E

 7,000 $66.38
» Full list on Insider Trading
Search Stocks